Robinson Value Management Ltd. Has $1.49 Million Stock Position in CVS Health Co. (NYSE:CVS)

Robinson Value Management Ltd. boosted its position in CVS Health Co. (NYSE:CVS) by 8.3% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 33,083 shares of the pharmacy operator’s stock after purchasing an additional 2,531 shares during the period. Robinson Value Management Ltd.’s holdings in CVS Health were worth $1,485,000 as of its most recent filing with the SEC.

Several other hedge funds have also bought and sold shares of the company. Stoneridge Investment Partners LLC lifted its position in CVS Health by 275.1% during the fourth quarter. Stoneridge Investment Partners LLC now owns 207,651 shares of the pharmacy operator’s stock worth $9,321,000 after acquiring an additional 152,296 shares during the last quarter. Thompson Investment Management Inc. lifted its position in CVS Health by 7.8% during the fourth quarter. Thompson Investment Management Inc. now owns 145,783 shares of the pharmacy operator’s stock worth $6,544,000 after acquiring an additional 10,534 shares during the last quarter. Empirical Finance LLC lifted its position in CVS Health by 17.8% during the fourth quarter. Empirical Finance LLC now owns 52,588 shares of the pharmacy operator’s stock worth $2,361,000 after acquiring an additional 7,959 shares during the last quarter. Moloney Securities Asset Management LLC lifted its position in CVS Health by 2.7% during the fourth quarter. Moloney Securities Asset Management LLC now owns 27,305 shares of the pharmacy operator’s stock worth $1,226,000 after acquiring an additional 708 shares during the last quarter. Finally, Kingsview Wealth Management LLC lifted its position in CVS Health by 9.1% during the fourth quarter. Kingsview Wealth Management LLC now owns 184,634 shares of the pharmacy operator’s stock worth $8,288,000 after acquiring an additional 15,400 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on CVS. Mizuho lowered their target price on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a report on Thursday, October 24th. TD Cowen raised their target price on shares of CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a report on Monday, November 25th. Piper Sandler lowered their target price on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a report on Monday, November 25th. Truist Financial lowered their target price on shares of CVS Health from $67.00 to $60.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Finally, UBS Group raised their target price on shares of CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a report on Thursday, November 7th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have issued a buy rating to the company’s stock. According to MarketBeat, CVS Health has a consensus rating of “Moderate Buy” and an average price target of $68.12.

CVS Health Price Performance

Shares of NYSE:CVS opened at $53.95 on Friday. The firm has a market cap of $67.90 billion, a PE ratio of 13.69, a price-to-earnings-growth ratio of 0.60 and a beta of 0.61. The firm’s fifty day moving average is $50.79 and its 200-day moving average is $56.01. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. CVS Health Co. has a 52 week low of $43.56 and a 52 week high of $80.75.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.08 by $0.01. The company had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. CVS Health’s revenue was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.21 earnings per share. Sell-side analysts predict that CVS Health Co. will post 5.14 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were issued a $0.665 dividend. The ex-dividend date was Thursday, January 23rd. This represents a $2.66 annualized dividend and a yield of 4.93%. CVS Health’s payout ratio is 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.